Long-term smoking behavior patterns predicting self-reported chronic bronchitis

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 6, Issue 4, 2009, Pages 242-249

  Hukkinen, Maria ^a   Korhonen, Tellervo ^a   Broms, Ulla ^a   Koskenvuo, Markku ^a   Kaprio, Jaakko ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Chronic bronchitis; Chronic obstructive pulmonary disease; Longitudinal study; Smoking

Indexed keywords

ADULT; ARTICLE; CHRONIC BRONCHITIS; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; HUMAN; INCIDENCE; LEISURE; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SELF REPORT; SMOKING CESSATION; TWIN DISCORDANCE;

ADULT; BRONCHITIS, CHRONIC; FEMALE; FINLAND; HUMANS; INCIDENCE; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; SMOKING;

EID: 70350445136     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.1080/15412550903051781     Document Type: Article

References (41)

1. Pelkonen M, Notkola IL, Nissinen A, Tukiainen H, Koskela H. Thirty-year cumulative incidence of chronic bronchitis and COPD in relation to 30-year pulmonary function and 40-year mortality: a follow-up in middle-aged rural men. Chest 2006 Oct; 130(4):1129-1137.
2. Pelkonen M. Smoking: relationship to chronic bronchitis, chronic obstructive pulmonary disease and mortality. Curr Opin Pulm Med 2008 Mar; 14(2):105-109.
3. Chronic obstructive pulmonary disease (COPD) (online). Current Care Summary. Working group set up by the Finnish Medical Society Duodecim and the Finnish Respiratory Society. Helsinki: The Finnish Medical Society Duodecim, 1999 (updated on 1March 2004). Available on the Internet at www.kaypahoito.fi.
4. Pauwels R. Global initiative for chronic obstructive lung diseases (GOLD): time to act. Eur Respir J 2001 Dec; 18(6):901-902.
5. Viegi G, Paoletti P, Prediletto R, Carrozzi L, Fazzi P, Di Pede F, Pistelli G, Giuntini C, Lebowitz MD. Prevalence of respiratory symptoms in an unpolluted area of northern Italy. Eur Respir J 1988 Apr; 1(4):311-318.
6. Kotaniemi J. Asthma, Chronic Obstructive Pulmonary Disease and Respiratory Symptoms among Adults: Prevalence and Risk Factors: The FinEsS Study in Northern Finland. Helsinki: University of Helsinki, 2006. http://ethesis.helsinki.fi/julkaisut/laa/kliin/ vk/kotaniemi2/.
7. Mannino DM. Chronic obstructive pulmonary disease: definition and epidemiology. Respir Care 2003 Dec; 48(12):1185-1191; discussion 1191-1193.
8. Terho EO, Koskenvuo M, Kaprio J. Atopy: a predisposing factor for chronic bronchitis in Finland. J Epidemiol Community Health 1995 Jun; 49(3):296-298.
9. Laasonen K, Uitti J. Bronchitis and emphysema as occupational diseases. Duodecim 2001; 117(2):156-161.
10. Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Anto JM. Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study. Am J Respir Crit Care Med 2007 Mar 1; 175(5):458-463.
11. de Marco R, Accordini S, Cerveri I, Corsico A, Anto JM, Kunzli N, Janson C, Sunyer J, Jarvis D, Chinn S, Vermeire P, Svanes C, Ackermann-Liebrich U, Gislason T, Heinrich J, Leynaert B, Neukirch F, Schouten JP, Wjst M, Burney P. Incidence of chronic obstructive pulmonary disease in a cohort of young adults according to the presence of chronic cough and phlegm. Am J Respir Crit Care Med 2007 Jan 1; 175(1):32-39.
12. Lange P, Parner J, Prescott E, Vestbo J. Chronic bronchitis in an elderly population. Age Ageing 2003 Nov; 32(6):636-642.
13. Vestbo J, Prescott E, Lange P. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group. Am J Respir Crit Care Med 1996 May; 153(5):1530-1535.
14. Willemse BW, Postma DS, Timens W, ten Hacken NH. The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation. Eur Respir J 2004 Mar; 23(3):464-476.
15. Cooper CB, DransfieldM. Primary care of the patient with chronic obstructive pulmonary disease-part 4: understanding the clinical manifestations of a progressive disease.Am JMed 2008 Jul; 121(7 Suppl):S33-45.
16. Tverdal A, Bjartveit K. Health consequences of reduced daily cigarette consumption. Tob Control 2006 Dec; 15(6):472-480.
17. Godtfredsen NS, Vestbo J, Osler M, Prescott E. Risk of hospital admission for COPD following smoking cessation and reduction: a Danish population study. Thorax 2002 Nov; 57(11):967-972.
18. National Cancer Institute. What's in a name? Examination of light and intermittent smokers. 2007. (NIH Publication No 07-6253) U.S. Department of Health and Human Services. Retrieved from http://cancercontrol.cancer.gov/TCRB/ LITSExecSummary.pdf.
19. Okuyemi KS, Harris KJ, Scheibmeir M, Choi WS, Powell J, Ahluwalia JS. Light smokers: issues and recommendations. Nicotine Tob Res 2002; 4(Suppl 2):S103-112.
20. Owen N, Kent P, Wakefield M, Roberts L. Low-rate smokers. Prev Med 1995 Jan; 24(1):80-84.
21. Vianna EO, Gutierrez MR, Barbieri MA, Caldeira RD, Bettiol H, Da Silva AA. Respiratory effects of tobacco smoking among young adults. Am J Med Sci 2008 Jul; 336(1):44-49.
22. Kaprio J, Koskenvuo M. Genetic and environmental factors in complex diseases: the older Finnish Twin Cohort. Twin Res 2002 Oct; 5(5):358-365. (Pubitemid 35315484)
23. Lebowitz MD, Burrows B. Comparison of questionnaires: the BMRC and NHLI respiratory questionnaires and a new self-completion questionnaire. Am Rev Respir Dis 1976 May; 113(5):627-635.
24. Kaprio J, Koskenvuo M. A prospective study of psychological and socioeconomic characteristics, health behavior and morbidity in cigarette smokers prior to quitting compared to persistent smokers and non-smokers. J Clin Epidemiol 1988; 41(2):139-150.
25. Korhonen T, Broms U, Varjonen J, Romanov K, Koskenvuo M, Kinnunen T, Kaprio J. Smoking behaviour as a predictor of depression among Finnish men and women: a prospective cohort study of adult twins. Psychol Med 2007 May; 37(5):705-715.
26. Kujala UM, Kaprio J, Koskenvuo M. Modifiable risk factors as predictors of all-cause mortality: the roles of genetics and childhood environment. Am J Epidemiol 2002 Dec 1; 156(11):985-993.
27. StataCorp. Stata Statistical Software. College Station, TX: Stata Corporation, 2005.
28. Williams RL. A note on robust variance estimation for clustercorrelated data. Biometrics 2000 Jun; 56(2):645-646.
29. Thomas DC. Statistical Methods in Genetic Epidemiology. New York: Oxford University Press; 2004.
30. Twisk JWR. Applied Longitudinal Data Analysis for Epidemiology: A Practical Guide. Cambridge, UK; New York: Cambridge University Press; 2003.
31. Pillai SG, Ge D, Zhu G, Kong X, Shianna KV, Need AC, Feng S, Hersh,CP, Bakke P, Gulsvik A, Ruppert A, Lodrup Carlsen KC, Roses A, Anderson W, Rennard SI, Lomas DA, Silverman EK, Goldstein DB, ICGN Investigators. A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. PLoS Genet 2009 Mar;5(3):e1000421.
32. Bierut LJ, Madden PA, Breslau N, Johnson EO, Hatsukami D, Pomerleau OF, Swan GE, Rutter J, Bertelsen S, Fox L, Fugman D, Goate AM, Hinrichs AL, Konvicka K, Martin NG, Montgomery GW, Saccone NL, Saccone SF, Wang JC, Chase GA, Rice JP, Ballinger DG. Novel genes identified in a highdensity genome wide association study for nicotine dependence. Hum Mol Genet 2007 Jan 1; 16(1):24-35.
33. Thorgeirsson TE, Geller F, Sulem P, Rafnar T, Wiste A, Magnusson KP, Manolescu A, Thorleifsson G, Stefansson H, Ingason A, Stacey SN, Bergthorsson JT, Thorlacius S, Gudmundsson J, Jonsson T, Jakobsdottir M, Saemundsdottir J, Olafsdottir O, Gudmundsson LJ, Bjornsdottir G, Kristjansson K, Skuladottir H, Isaksson HJ, Gudbjartsson T, Jones GT, Mueller T, Gottsater A, Flex A, Aben KK, de Vegt F, Mulders PF, Isla D, Vidal MJ, Asin L, Saez B, Murillo L, Blondal T, Kolbeinsson H, Stefansson JG, Hansdottir I, Runarsdottir V, Pola R, Lindblad B, van Rij AM, Dieplinger B, Haltmayer M, Mayordomo JI, Kiemeney LA, Matthiasson SE, Oskarsson H, Tyrfingsson T, Gudbjartsson DF, Gulcher JR, Jonsson S, Thorsteinsdottir U, Kong A, Stefansson K.A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 2008 Apr 3; 452(7187):638-642.
34. Weiss RB, Baker TB, Cannon DS, von Niederhausern A, Dunn DM, Matsunami N, Singh NA, Baird L, Coon H, McMahon WM, Piper ME, Fiore MC, Scholand MB, Connett JE, Kanner RE, Gahring LC, Rogers SW, Hoidal JR, Leppert MF. A candidate gene approach identifies the CHRNA5-A3-B4 region as a risk factor for age-dependent nicotine addiction. PLoS Genet 2008 Jul;4(7):e1000125.
35. Hukkinen M, Kaprio J, Broms U, Koskenvuo M, Korhonen T. Characteristics and consistency of light smoking: long-term followup among Finnish adults. Nicotine Tob Res 2009 7 May [Epub ahead of print].
36. Bobadilla A, Guerra S, Sherrill D, Barbee R. How accurate is the self-reported diagnosis of chronic bronchitis? Chest 2002 Oct; 122(4):1234-1239.
37. Vestbo J, Lange P. Can GOLD Stage 0 provide information of prognostic value in chronic obstructive pulmonary disease?[see comment]. Am J Respir Crit Care Med 2002 Aug 1;166(3):329-332. (Pubitemid 34864421)
38. Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD).[see comment]. Lancet 2004 Aug 14-20; 364(9434):613-620.
39. van Schayck CP, Halbert RJ, Nordyke RJ, Isonaka S, Maroni J, Nonikov D. Comparison of existing symptom-based questionnaires for identifying COPD in the general practice setting. Respirology 2005 Jun; 10(3):323-333.
40. Kotaniemi, J, Sovijarvi A, Lundback B. Chronic obstructive pulmonary disease in Finland: prevalence and risk factors. COPD 2005 Sep; 2(3):331-339.
41. Marsh SE, Travers J, Weatherall M, Williams MV, Aldington S, Shirtcliffe PM, Hansell AL, Nowitz MR, McNaughton AA, Soriano JB, Beasley RW. Proportional classifications of COPD phenotypes. Thorax 2008 Sep; 63(9):761-767.